Targacept Reports Fourth Quarter and 2013 Financial Results
[Business Wire] – Targacept, Inc. , a clinical-stage biopharmaceutical company developing novel NNR Therapeuticsâ„¢, today reported its financial results for the fourth quarter and year more
View todays social media effects on TRGT
View the latest stocks trending across Twitter. Click to view dashboard